FrancophonIA/ELRC3.0 huggingface dataset:
English: What Neoclarityn contains
Estonian: Mida Neoclarityn sisaldab
English: Neoclarityn tablets contain lactose.
Estonian: Neoclarityni tabletid sisaldavad laktoosi.
English: What Neoclarityn is Neoclarityn contains desloratadine which is an antihistamine.
Estonian: Mis ravim on Neoclarityn Neoclarityn sisaldab desloratadiini, mis on antihistamiin.
English: In two placebo-controlled six week trials in patients with chronic idiopathic urticaria, Neoclarityn was effective in relieving pruritus and decreasing the size and number of hives by the end of the first dosing interval.
Estonian: Kahes platseebokontrollitud 6-nädalases kroonilise idiopaatilise urtikaaria uuringus vähendas Neoclarityn efektiivselt sügelust ja kuplade suurust ning arvu juba esimese ravipäeva lõpuks.
English: Neoclarityn 2.5 mg tablets has not been evaluated in paediatric patients however in conjunction with the dose finding studies in paediatrics, the pharmacokinetics data for Neoclarityn orodispersible tablets supports the use of the 2.5 mg dose in paediatric patients 6 to 11 years of age.
Estonian: Neoclarityni 2,5 mg tablette ei ole uuritud lastel, kuigi lähtuvalt lastel läbi viidud annustamise uuringutest toetavad Neoclarityni suus dispergeeruvate tablettide farmakokineetilised andmed 2,5 mg annuse kasutamist lastel vanuses 6 kuni 11 aastat.
English: Therefore, the efficacy of Neoclarityn orodispersible tablet is expected to be the same as with the Neoclarityn tablet formulation.
Estonian: Seetõttu on Neoclarityni suus dispergeeruva tableti oodatav efektiivsus võrdne Neoclarityni tabletiga.
English: When Neoclarityn should be used
Estonian: Millal tuleb Neoclarityni kasutada
English: In clinical studies with Neoclarityn, the following side effects were reported as:
Estonian: Neoclarityniga läbi viidud kliinilistes uuringutes teatati järgmistest kõrvaltoimetest:
English: In a clinical pharmacology trial, Neoclarityn tablets taken concomitantly with alcohol did not potentiate the performance impairing effects of alcohol (see section 5.1).
Estonian: Kliinilise farmakoloogia uuringus ei potentseerinud Neoclarityni tabletid samaaegselt manustatuna alkoholi toimet (vt lõik 5.1).
English: If you forget to take Neoclarityn
Estonian: Kui te unustate Neoclarityni võtta
English: Neoclarityn orodispersible tablet contains aspartame This product contains aspartame.
Estonian: Neoclarityni suus dispergeeruv tablett sisaldab aspartaami See ravim sisaldab aspartaami.
English: If you forget to take Neoclarityn orodispersible tablet If you forget to take your dose on time, take it as soon as possible and then go back to your regular dosing schedule.
Estonian: Kui te unustate Neoclarityni suus dispergeeruvat tabletti võtta Kui te unustasite oma annuse õigel ajal võtmata, siis tehke seda nii ruttu kui võimalik ja jätkake seejärel tavapärase annustamisega.
English: Neoclarityn contains lactose
Estonian: Neoclarityn sisaldab laktoosi
English: What you need to know before you take Neoclarityn
Estonian: Mida on vaja teada enne Neoclarityni võtmist
English: During the marketing of Neoclarityn, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling) have been reported very rarely.
Estonian: Neoclarityni turuletulekujärgselt on väga harva teatatud tõsistest allergilistest reaktsioonidest (hingamisraskus, vilisev hingamine, sügelus, nõgeslööve ja turse).
English: However, the safety of desloratadine syrup formulation, which contains the same concentration of desloratadine as Neoclarityn oral solution, was demonstrated in three paediatric trials.
Estonian: Siiski on desloratadiini siirupi ravimvormi, mis sisaldab samas kontsentratsioonis desloratadiini kui Neoclarityni suukaudne lahus, ohutus näidatud kolmes laste uuringus.
English: Neoclarityn oral solution, is supplied in 30, 50, 60, 100, 120, 150, 225 and 300 ml size Type III amber glass bottles closed with a plastic child resistant (C/R) screw closure having a multi-ply polyethylenefaced liner.
Estonian: Neoclarityni suukaudne lahus on saadaval 30, 50, 60, 100, 120, 150, 225 või 300 ml III tüüpi merevaigukollasest klaasist pudelis, mis on suletud plastist keeratava lastekindla korgiga ning kaetud mitmekihilise polüetüleenkilega.
English: Talk to your doctor, pharmacist or nurse before taking Neoclarityn: - if you have poor kidney function.
Estonian: Enne Neoclarityni võtmist pidage nõu oma arsti, apteekri või meditsiiniõega, - kui teie neerutalitlus on nõrgenenud; - kui teil või teie pereliikmetel on esinenud krambihoogusid.
English: Do not use this medicine if you notice any change in the appearance of Neoclarityn orodispersible tablet.
Estonian: Ärge kasutage seda ravimit, kui täheldate muutusi Neoclarityni suus dispergeeruva tableti välimuses.
English: What Neoclarityn is and what it is used for What you need to know before you take Neoclarityn How to take Neoclarityn
Estonian: Mis ravim on Neoclarityn ja milleks seda kasutatakse Mida on vaja teada enne Neoclarityni võtmist Kuidas Neoclarityni võtta
English: Adverse reactions seen with Neoclarityn
Estonian: Esinemissagedus Neoclarityniga täheldatud kõrvaltoimed
English: Neoclarityn 2.5 mg orodispersible tablet is light red, speckled, and round with “K” branded on one side.
Estonian: Neoclarityni 2,5 mg suus dispergeeruv tablett on helepunane, tähniline, ümar ning ühel küljel on märgistus „K”.
English: Neoclarityn has no or negligible influence on the ability to drive and use machines based on clinical trials.
Estonian: Lähtudes kliinilistest uuringutest Neoclaritynil ei ole või on ebaoluline toime autojuhtimise ja masinate käsitsemise võimele.
English: The recommended dose of Neoclarityn is two 2.5 mg orodispersible tablets placed in the mouth once a day.
Estonian: Soovitatav Neoclarityni annus on üks 2,5 mg suus dispergeeruv tablett asetatuna suhu üks kord päevas.
English: Children 1 through 5 years of age: 2.5 ml (1.25 mg) Neoclarityn oral solution once a day.
Estonian: 1...5-aastased lapsed: 2,5 ml (1,25 mg) Neoclarityni suukaudset lahust üks kord päevas.
English: What Neoclarityn looks like and contents of the pack
Estonian: Kuidas Neoclarityn välja näeb ja pakendi sisu
English: During the marketing of Neoclarityn, the following side effects were reported as:
Estonian: Neoclarityni turuletulekujärgselt teatati järgmistest kõrvaltoimetest:
English: What Neoclarityn is and what it is used for
Estonian: Mis ravim on Neoclarityn ja milleks seda kasutatakse
English: Neoclarityn orodispersible tablet with food, drink and alcohol Neoclarityn orodispersible tablet does not need to be taken with water or liquid.
Estonian: Neoclarityni suus dispergeeruv tablett koos toidu, joogi ja alkoholiga Neoclarityni suus dispergeeruvat tabletti saab võtta ilma vee või muu vedelikuta.
English: Neoclarityn 5 mg orodispersible tablet is light red, speckled, and round with “A” branded on one side.
Estonian: Neoclarityni 5 mg suus dispergeeruv tablett on helepunane, tähniline, ümar ning ühel küljel on märgistus „A”.
English: What Neoclarityn orodispersible tablet is and what it is used for What you need to know before you take Neoclarityn orodispersible tablet How to take Neoclarityn orodispersible tablet Possible side effects
Estonian: Mis ravim on Neoclarityni suus dispergeeruv tablett ja milleks seda kasutatakse Mida on vaja teada enne Neoclarityni suus dispergeeruva tableti võtmist Kuidas Neoclarityni suus dispergeeruvat tabletti võtta Võimalikud kõrvaltoimed
English: How to take Neoclarityn
Estonian: Kuidas Neoclarityni võtta
English: Adults During the marketing of Neoclarityn, the following side effects were reported as:
Estonian: Täiskasvanud Neoclarityni turuletulekujärgselt teatati järgmistest kõrvaltoimetest:
English: How to store Neoclarityn orodispersible tablet Contents of the pack and other information
Estonian: Kuidas Neoclarityni suukaudset lahust säilitada Pakendi sisu ja muu teave
English: Neoclarityn 5 mg film-coated tablets are packed in blisters in packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 or 100 tablets.
Estonian: Neoclarityni 5 mg õhukese polümeerikattega tabletid on pakendatud blisterpakenditesse, mis sisaldavad 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 või 100 tabletti pakendis.
English: In single-dose crossover studies of Neoclarityn 5 mg orodispersible tablets with Neoclarityn 5 mg conventional tablets, the formulations were bioequivalent.
Estonian: Ühekordse annusega Neoclarityni 5 mg suus dispergeeruvate tablettide ja Neoclarityni 5 mg tavapäraste tablettide ristuuringus olid ravimvormid bioekvivalentsed.
English: Neoclarityn with food, drink and alcohol Neoclarityn may be taken with or without a meal.
Estonian: Neoclarityni suukaudne lahus koos toidu, joogi ja alkoholiga Neoclarityni võib võtta koos toiduga või ilma toiduta.
English: Neoclarityn is an antiallergy medicine that does not make you drowsy.
Estonian: Neoclarityn on allergiavastane ravim, mis ei tee teid uniseks.
English: In clinical studies in most children and adults, side effects with Neoclarityn were about the same as with a dummy solution or tablet.
Estonian: Enamikul täiskasvanutel ja lastel esines kliinilistes uuringutes Neoclarityniga kõrvaltoimeid samas sageduses toimeta lahust või tabletti võtnutega.
English: This product contains 1.4 mg of phenylalanine per 2.5 mg dose of Neoclarityn orodispersible tablet.
Estonian: See ravim sisaldab 1,4 mg fenüülalaniini 2,5 mg Neoclarityni suus dispergeeruva tableti kohta.
English: 1 film-coated tablet 2 film-coated tablets 3 film-coated tablets 5 film-coated tablets 7 film-coated tablets 10 film-coated tablets 14 film-coated tablets 15 film-coated tablets 20 film-coated tablets 21 film-coated tablets 30 film-coated tablets 50 film-coated tablets 100 film-coated tablets
Estonian: 1 õhukese polümeerikattega tablett 2 õhukese polümeerikattega tabletti 3 õhukese polümeerikattega tabletti 5 õhukese polümeerikattega tabletti 7 õhukese polümeerikattega tabletti 10 õhukese polümeerikattega tabletti 14 õhukese polümeerikattega tabletti 15 õhukese polümeerikattega tabletti 20 õhukese polümeerikattega tabletti 21 õhukese polümeerikattega tabletti 30 õhukese polümeerikattega tabletti 50 õhukese polümeerikattega tabletti 100 õhukese polümeerikattega tabletti
English: How Neoclarityn works
Estonian: Kuidas Neoclarityn toimib
English: Neoclarityn orodispersible tablet is packed in unit dose blisters in packs of 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 and 100 doses of orodispersible tablet.
Estonian: Neoclarityni suus dispergeeruv tablett on pakendatud üheannuselistesse blisterpakenditesse, mis sisaldavad 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 või 100 annust suus dispergeeruvat tabletti pakendis.
English: At the recommended dose, Neoclarityn 5 mg orodispersible tablet was found to be bioequivalent to the Neoclarityn 5 mg conventional tablet formulation of desloratadine.
Estonian: Soovitavas annuses oli Neoclarityni 5 mg suus dispergeeruv tablett bioekvivalentne desloratadiini ühe teise ravimvormi, Neoclarityni 5 mg tavapärase tabletivormiga.
English: EU/1/00/161/001 1 tablet EU/1/00/161/002 2 tablets EU/1/00/161/003 3 tablets EU/1/00/161/004 5 tablets EU/1/00/161/005 7 tablets EU/1/00/161/006 10 tablets EU/1/00/161/007 14 tablets EU/1/00/161/008 15 tablets EU/1/00/161/009 20 tablets EU/1/00/161/010 21 tablets EU/1/00/161/011 30 tablets EU/1/00/161/012 50 tablets EU/1/00/161/013 100 tablets
Estonian: EU/1/00/161/001 1 tablett EU/1/00/161/002 2 tabletti EU/1/00/161/003 3 tabletti EU/1/00/161/004 5 tabletti EU/1/00/161/005 7 tabletti EU/1/00/161/006 10 tabletti EU/1/00/161/007 14 tabletti EU/1/00/161/008 15 tabletti EU/1/00/161/009 20 tabletti EU/1/00/161/010 21 tabletti EU/1/00/161/011 30 tabletti EU/1/00/161/012 50 tabletti EU/1/00/161/013 100 tabletti
English: Do not take Neoclarityn - if you are allergic to desloratadine, or any of the other ingredients of this medicine (listed in section 6) or to loratadine.
Estonian: Ärge võtke Neoclarityni, - kui olete desloratadiini või selle ravimi mis tahes koostisosade (loetletud lõigus 6) või loratadiini suhtes allergiline.
English: Neoclarityn is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Estonian: Neoclarityn on näidustatud täiskasvanutel, noorukitel ja lastel vanuses üle 1 aasta järgmiste haiguste sümptomaatiliseks raviks: - allergiline riniit (vt lõik 5.1); - urtikaaria (vt lõik 5.1).
English: Children 6 through 11 years of age: 5 ml (2.5 mg) Neoclarityn oral solution once a day.
Estonian: 6...11-aastased lapsed: 5 ml (2,5 mg) Neoclarityni suukaudset lahust üks kord päevas.
English: This product contains 2.9 mg of phenylalanine per 5 mg dose of Neoclarityn orodispersible tablet.
Estonian: See ravim sisaldab 2,9 mg fenüülalaniini 5 mg Neoclarityni suus dispergeeruva tableti kohta.
English: Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Neoclarityn.
Estonian: Ravi kestuse selgitamiseks teeb teie arst esmalt kindlaks, mis tüüpi allergiline riniit teil esineb, ning seejärel määrab, kui kaua te peate Neoclarityni võtma.
English: Name and address of the manufacturer responsible for batch release for film coated tablets
Estonian: Suus dispergeeruvate tablettide ravimipartii kasutamiseks vabastamise eest vastutava tootja nimi ja aadress
English: What you need to know before you take Neoclarityn orodispersible tablet
Estonian: Mida on vaja teada enne Neoclarityni suus dispergeeruva tableti võtmist
English: Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Neoclarityn orodispersible tablets.
Estonian: Ravi kestuse selgitamiseks teeb teie arst esmalt kindlaks, mis tüüpi allergiline riniit teil esineb, ning seejärel määrab, kui kaua te peate Neoclarityni suus dispergeeruvat tabletti võtma.
English: Neoclarityn is indicated in adults, adolescents aged 12 years and older and children aged 6 - 11 years old for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Estonian: Neoclarityn on näidustatud täiskasvanutel, noorukitel vanuses 12 aastat ja vanemad ning lastel vanuses 6…11 aastat järgmiste haiguste sümptomaatiliseks raviks: - allergiline riniit (vt lõik 5.1); - urtikaaria (vt lõik 5.1).
English: Neoclarityn orodispersible tablets are supplied in unit dose blisters comprised of laminate blister film with foil lidding.
Estonian: Neoclarityni suus dispergeeruvad tabletid on saadaval üheannuselises alumiiniumfooliumiga kaetud lamineeritud blistris.
English: Efficacy of Neoclarityn syrup has not been investigated in paediatric trials in children less than 12 years of age.
Estonian: Lasteuuringutes ei ole Neoclarityni siirupi efektiivsust noorematel kui 12-aastastel lastel uuritud.
English: Do not take Neoclarityn orodispersible tablet - if you are allergic to desloratadine, or any of the other ingredients of this medicine (listed in section 6) or to loratadine.
Estonian: Ärge võtke Neoclarityni suukaudset lahust, - kui olete desloratadiini või selle ravimi mis tahes koostisosade (loetletud lõigus 6) või loratadiini suhtes allergiline.
English: EU/1/00/161/059 30 ml with 1 spoon EU/1/00/161/060 50 ml with 1 spoon EU/1/00/161/061 60 ml with 1 spoon EU/1/00/161/062 100 ml with 1 spoon EU/1/00/161/063 120 ml with 1 spoon EU/1/00/161/064 150 ml with 1 spoon EU/1/00/161/067 150 ml with 1 oral syringe EU/1/00/161/065 225 ml with 1 spoon EU/1/00/161/066 300 ml with 1 spoon
Estonian: EU/1/00/161/059 30 ml, kaasas 1 mõõtelusikas EU/1/00/161/060 50 ml, kaasas 1 mõõtelusikas EU/1/00/161/061 60 ml, kaasas 1 mõõtelusikas EU/1/00/161/062 100 ml, kaasas 1 mõõtelusikas EU/1/00/161/063 120 ml, kaasas 1 mõõtelusikas EU/1/00/161/064 150 ml, kaasas 1 mõõtelusikas EU/1/00/161/067 150 ml, kaasas 1 mõõdikuga suusüstal EU/1/00/161/065 225 ml, kaasas 1 mõõtelusikas EU/1/00/161/066 300 ml, kaasas 1 mõõtelusikas
English: Neoclarityn orodispersible tablet is an antiallergy medicine that does not make you drowsy.
Estonian: Neoclarityni suus dispergeeruv tablett on allergiavastane ravim, mis ei tee teid uniseks.
English: The safety and efficacy of Neoclarityn 0.5 mg/ml oral solution in children below the age of 1 year have not been established.
Estonian: Neoclarityni 0,5 mg/ml suukaudse lahuse ohutus ja efektiivsus lastel vanuses alla 1 aasta ei ole tõestatud.
English: How to store Neoclarityn oral solution Contents of the pack and other information
Estonian: Kuidas Neoclarityni säilitada Pakendi sisu ja muu teave
English: What Neoclarityn orodispersible tablet is and what it is used for
Estonian: Mis ravim on Neoclarityni suukaudne lahus ja milleks seda kasutatakse
English: Efficacy of Neoclarityn oral solution has not been investigated in separate paediatric trials.
Estonian: Neoclarityni suukaudse lahuse efektiivsust ei ole lastel eraldi uuritud.
English: How to store Neoclarityn
Estonian: Kuidas Neoclarityni säilitada
English: Adults and adolescents (12 years of age and over) The recommended dose of Neoclarityn is one tablet once a day.
Estonian: Täiskasvanud ja noorukid (vanuses 12 aastat ja vanemad) Soovitatav Neoclarityni annus on üks tablett üks kord päevas.
English: Neoclarityn is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Estonian: Neoclarityn on näidustatud täiskasvanutel ja noorukitel vanuses 12 aastat ja vanemad järgmiste haiguste sümptomaatiliseks raviks: - allergiline riniit (vt lõik 5.1); - urtikaaria (vt lõik 5.1).
English: If you stop taking Neoclarityn orodispersible tablet If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Estonian: Kui te lõpetate Neoclarityni suus dispergeeruva tableti võtmise Kui teil on lisaküsimusi selle ravimi kasutamise kohta, pidage nõu oma arsti, apteekri või meditsiiniõega.
English: If you stop taking Neoclarityn If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Estonian: Kui te lõpetate Neoclarityni suukaudse lahuse võtmise Kui teil on lisaküsimusi selle ravimi kasutamise kohta, pidage nõu oma arsti, apteekri või meditsiiniõega.
English: Neoclarityn is supplied in blisters comprised of laminate blister film with foil lidding.
Estonian: Neoclarityn on saadaval alumiiniumfooliumiga kaetud lamineeritud blistris.
English: BOX OF 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 100 TABLETS
Estonian: 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 100 TABLETTI KARBIS
English: The efficacy of Neoclarityn tablets has not been clearly demonstrated in trials with adolescent patients 12 through 17 years of age.
Estonian: Noorukitel vanuses 12 kuni 17 aastat läbi viidud uuringutes ei ole Neoclarityni tablettide efektiivsus selgelt tõestatud.
English: The safety and efficacy of Neoclarityn 2.5 mg orodispersible tablets in children below the age of 6 years have not been established.
Estonian: Neoclarityni 2,5 mg suus dispergeeruvate tablettide ohutus ja efektiivsus lastel vanuses alla 6 aasta ei ole tõestatud.
English: Adults and adolescents (12 years of age and over) The recommended dose of Neoclarityn is one 5 mg orodispersible tablet placed in the mouth once a day.
Estonian: Täiskasvanud ja noorukid (vanuses 12 aastat ja vanemad) Soovitatav Neoclarityni annus on üks 5 mg suus dispergeeruv tablett asetatuna suhu üks kord päevas.
English: Neoclarityn 0.5 mg/ml oral solution
Estonian: Neoclarityn 0,5 mg/ml
English: Neoclarityn oral solution is an antiallergy medicine that does not make you drowsy.
Estonian: Neoclarityni suukaudne lahus on allergiavastane ravim, mis ei tee teid uniseks.
English: Neoclarityn tablets given at a single daily dose of 7.5 mg to adults and adolescents did not affect psychomotor performance in clinical trials.
Estonian: Kliinilistes uuringutes ei mõjutanud täiskasvanutele ja noorukitele ühekordse 7,5 mg annusena manustatud Neoclarityni tabletid psühhomotoorset võimekust.
English: Packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 100 tablets.
Estonian: 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 või 100 tabletti pakis.
English: EU/1/00/161/035 5 orodispersible tablets EU/1/00/161/036 6 orodispersible tablets EU/1/00/161/037 10 orodispersible tablets EU/1/00/161/038 12 orodispersible tablets EU/1/00/161/039 15 orodispersible tablets EU/1/00/161/040 18 orodispersible tablets EU/1/00/161/041 20 orodispersible tablets EU/1/00/161/042 30 orodispersible tablets EU/1/00/161/043 50 orodispersible tablets EU/1/00/161/044 60 orodispersible tablets EU/1/00/161/045 90 orodispersible tablets EU/1/00/161/046 100 orodispersible tablets
Estonian: EU/1/00/161/035 5 suus dispergeeruvat tabletti EU/1/00/161/036 6 suus dispergeeruvat tabletti EU/1/00/161/037 10 suus dispergeeruvat tabletti EU/1/00/161/038 12 suus dispergeeruvat tabletti EU/1/00/161/039 15 suus dispergeeruvat tabletti EU/1/00/161/040 18 suus dispergeeruvat tabletti EU/1/00/161/041 20 suus dispergeeruvat tabletti EU/1/00/161/042 30 suus dispergeeruvat tabletti EU/1/00/161/043 50 suus dispergeeruvat tabletti EU/1/00/161/044 60 suus dispergeeruvat tabletti EU/1/00/161/045 90 suus dispergeeruvat tabletti EU/1/00/161/046 100 suus dispergeeruvat tabletti
English: However, if you take more Neoclarityn than you were told to, tell your doctor, pharmacist or nurse immediately.
Estonian: Kui te siiski olete võtnud Neoclarityni rohkem kui ette nähtud, pidage kohe nõu oma arsti, apteekri või meditsiiniõega.
English: Neoclarityn oral solution contains sorbitol.
Estonian: See ravim sisaldab sorbitooli.
English: What Neoclarityn orodispersible tablet contains
Estonian: Mida Neoclarityni suus dispergeeruv tablett sisaldab
English: The safety and efficacy of Neoclarityn 5 mg orodispersible tablets in children below the age of 12 years have not been established.
Estonian: Neoclarityni 5 mg suus dispergeeruvate tablettide ohutus ja efektiivsus lastel vanuses alla 12 aasta ei ole tõestatud.
English: In adult and adolescent patients with allergic rhinitis, Neoclarityn tablets were effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate.
Estonian: Allergilise riniidiga noorukitel ja täiskasvanud patsientidel vähendasid Neoclarityni tabletid efektiivselt järgmisi sümptomeid: aevastamine, vesine nohu, nina sügelus, silmade sügelemine, pisaravool ja punetus, suulae sügelus.
English: EU/1/00/161/047 5 orodispersible tablets EU/1/00/161/048 6 orodispersible tablets EU/1/00/161/049 10 orodispersible tablets EU/1/00/161/050 12 orodispersible tablets EU/1/00/161/051 15 orodispersible tablets EU/1/00/161/052 18 orodispersible tablets EU/1/00/161/053 20 orodispersible tablets EU/1/00/161/054 30 orodispersible tablets EU/1/00/161/055 50 orodispersible tablets EU/1/00/161/056 60 orodispersible tablets EU/1/00/161/057 90 orodispersible tablets EU/1/00/161/058 100 orodispersible tablets
Estonian: EU/1/00/161/047 5 suus dispergeeruvat tabletti EU/1/00/161/048 6 suus dispergeeruvat tabletti EU/1/00/161/049 10 suus dispergeeruvat tabletti EU/1/00/161/050 12 suus dispergeeruvat tabletti EU/1/00/161/051 15 suus dispergeeruvat tabletti EU/1/00/161/052 18 suus dispergeeruvat tabletti EU/1/00/161/053 20 suus dispergeeruvat tabletti EU/1/00/161/054 30 suus dispergeeruvat tabletti EU/1/00/161/055 50 suus dispergeeruvat tabletti EU/1/00/161/056 60 suus dispergeeruvat tabletti EU/1/00/161/057 90 suus dispergeeruvat tabletti EU/1/00/161/058 100 suus dispergeeruvat tabletti
English: Clinical efficacy and safety In a multiple dose trial, Neoclarityn orodispersible tablets were well tolerated.
Estonian: Mitmekordsete annustega läbi viidud uuringus olid Neoclarityni suus dispergeeruvad tabletid hästi talutavad.
English: How to store Neoclarityn orodispersible tablet
Estonian: Kuidas Neoclarityni suus dispergeeruvat tabletti säilitada
English: Neoclarityn 5 mg tablet desloratadine
Estonian: Neoclarityn 5 mg tabletid desloratadiin